Susan L. Cohn to Granulocyte-Macrophage Colony-Stimulating Factor
This is a "connection" page, showing publications Susan L. Cohn has written about Granulocyte-Macrophage Colony-Stimulating Factor.
Connection Strength
0.258
-
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group. J Clin Oncol. 2022 12 10; 40(35):4107-4118.
Score: 0.211
-
Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study. J Clin Oncol. 2010 Nov 20; 28(33):4969-75.
Score: 0.023
-
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 2010 Sep 30; 363(14):1324-34.
Score: 0.023